278 related articles for article (PubMed ID: 27919698)
1. The use of partially hydrolysed polyvinyl alcohol for the production of high drug-loaded sustained release pellets via extrusion-spheronisation and coating: In vitro and in vivo evaluation.
Verstraete G; De Jaeghere W; Vercruysse J; Grymonpré W; Vanhoorne V; Stauffer F; De Beer T; Bezuijen A; Remon JP; Vervaet C
Int J Pharm; 2017 Jan; 517(1-2):88-95. PubMed ID: 27919698
[TBL] [Abstract][Full Text] [Related]
2. Design and in vitro and in vivo characterization of mucoadhesive matrix pellets of metformin hydrochloride for oral controlled release: a technical note.
Ige PP; Gattani SG
Arch Pharm Res; 2012 Mar; 35(3):487-98. PubMed ID: 22477196
[TBL] [Abstract][Full Text] [Related]
3. Use of kappa-carrageenan as alternative pelletisation aid to microcrystalline cellulose in extrusion/spheronisation. II. Influence of drug and filler type.
Thommes M; Kleinebudde P
Eur J Pharm Biopharm; 2006 May; 63(1):68-75. PubMed ID: 16325384
[TBL] [Abstract][Full Text] [Related]
4. Production of pellets via extrusion-spheronisation without the incorporation of microcrystalline cellulose: a critical review.
Dukić-Ott A; Thommes M; Remon JP; Kleinebudde P; Vervaet C
Eur J Pharm Biopharm; 2009 Jan; 71(1):38-46. PubMed ID: 18771727
[TBL] [Abstract][Full Text] [Related]
5. In-vitro and in-vivo evaluation of enteric-coated starch-based pellets prepared via extrusion/spheronisation.
Dukić-Ott A; De Beer T; Remon JP; Baeyens W; Foreman P; Vervaet C
Eur J Pharm Biopharm; 2008 Sep; 70(1):302-12. PubMed ID: 18579353
[TBL] [Abstract][Full Text] [Related]
6. Use of kappa-carrageenan as alternative pelletisation aid to microcrystalline cellulose in extrusion/spheronisation. I. Influence of type and fraction of filler.
Thommes M; Kleinebudde P
Eur J Pharm Biopharm; 2006 May; 63(1):59-67. PubMed ID: 16326085
[TBL] [Abstract][Full Text] [Related]
7. Drug release mechanisms from ethylcellulose: PVA-PEG graft copolymer-coated pellets.
Muschert S; Siepmann F; Leclercq B; Carlin B; Siepmann J
Eur J Pharm Biopharm; 2009 May; 72(1):130-7. PubMed ID: 19146955
[TBL] [Abstract][Full Text] [Related]
8. Preparation and in vitro/in vivo evaluation of sustained-release metformin hydrochloride pellets.
Hu LD; Liu Y; Tang X; Zhang Q
Eur J Pharm Biopharm; 2006 Oct; 64(2):185-92. PubMed ID: 16797948
[TBL] [Abstract][Full Text] [Related]
9. Quantification of mass transfer during spheronisation.
Koester M; Thommes M
AAPS PharmSciTech; 2012 Jun; 13(2):493-7. PubMed ID: 22415640
[TBL] [Abstract][Full Text] [Related]
10. Preparation and in vitro/in vivo evaluation of sustained-release venlafaxine hydrochloride pellets.
Liu Y; Sun Y; Sun J; Zhao N; Sun M; He Z
Int J Pharm; 2012 Apr; 426(1-2):21-28. PubMed ID: 22266529
[TBL] [Abstract][Full Text] [Related]
11. Hydrophilic thermoplastic polyurethanes for the manufacturing of highly dosed oral sustained release matrices via hot melt extrusion and injection molding.
Verstraete G; Van Renterghem J; Van Bockstal PJ; Kasmi S; De Geest BG; De Beer T; Remon JP; Vervaet C
Int J Pharm; 2016 Jun; 506(1-2):214-21. PubMed ID: 27113866
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the coat quality of sustained release pellets by individual pellet dissolution methodology.
Xu M; Liew CV; Heng PWS
Int J Pharm; 2015 Jan; 478(1):318-327. PubMed ID: 25435182
[TBL] [Abstract][Full Text] [Related]
13. Micropellet-loaded rods with dose-independent sustained release properties for individual dosing via the Solid Dosage Pen.
Laukamp EJ; Knop K; Thommes M; Breitkreutz J
Int J Pharm; 2016 Feb; 499(1-2):271-279. PubMed ID: 26757149
[TBL] [Abstract][Full Text] [Related]
14. Formulation and characterization of acetaminophen nanoparticles in orally disintegrating films.
Al-Nemrawi NK; Dave RH
Drug Deliv; 2016; 23(2):540-9. PubMed ID: 25013958
[TBL] [Abstract][Full Text] [Related]
15. Drug release from MCC- and carrageenan-based pellets: experiment and theory.
Kranz H; Jürgens K; Pinier M; Siepmann J
Eur J Pharm Biopharm; 2009 Oct; 73(2):302-9. PubMed ID: 19465119
[TBL] [Abstract][Full Text] [Related]
16. A 3D printed bilayer oral solid dosage form combining metformin for prolonged and glimepiride for immediate drug delivery.
Gioumouxouzis CI; Baklavaridis A; Katsamenis OL; Markopoulou CK; Bouropoulos N; Tzetzis D; Fatouros DG
Eur J Pharm Sci; 2018 Jul; 120():40-52. PubMed ID: 29678613
[TBL] [Abstract][Full Text] [Related]
17. Formulation and evaluation of mefenamic acid sustained release matrix pellets.
Ibrahim MA
Acta Pharm; 2013 Mar; 63(1):85-98. PubMed ID: 23482315
[TBL] [Abstract][Full Text] [Related]
18. Development of starch-based pellets via extrusion/spheronisation.
Dukić A; Mens R; Adriaensens P; Foreman P; Gelan J; Remon JP; Vervaet C
Eur J Pharm Biopharm; 2007 Apr; 66(1):83-94. PubMed ID: 17045467
[TBL] [Abstract][Full Text] [Related]
19. Use of crospovidone as pelletization aid as alternative to microcrystalline cellulose: effects on pellet properties.
Verheyen P; Steffens KJ; Kleinebudde P
Drug Dev Ind Pharm; 2009 Nov; 35(11):1325-32. PubMed ID: 19832632
[TBL] [Abstract][Full Text] [Related]
20. Immediate release pellets with lipid binders obtained by solvent-free cold extrusion.
Krause J; Thommes M; Breitkreutz J
Eur J Pharm Biopharm; 2009 Jan; 71(1):138-44. PubMed ID: 18805483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]